Jump to content
PC Security Forum
FORUMS BLOG/NEWS USER BLOGS USER MEDIA ADVERTS   ADD  MANAGE CHAT CLUBS & USER'S PERSONAL FORUMS LINK EXCHANGE

Blogs

The medical device batteries market is estimated to be worth USD 3.10 billion in 2030 (Roots Analysis)

Batteries play an important role in the overall performance and safety of many modern healthcare solutions; as more hand-held and point-of-care medical devices are introduced, the corresponding need for reliable power sources is also on the rise   Roots Analysis is pleased to announce the publication of its recent study, titled, “Medical Device Batteries: Focus on Implants and Wearable Medical Devices - Market Distribution by Battery Chemistry (Lithium, Zinc Air, Nickel and Others), Re

The medical device batteries market is projected to grow at an annualized rate of 12%, <Roots Analysis>

An exponential increase in development efforts related to wearable medical devices and implants, has fueled a corresponding rise in demand for safe, compact, light-weight and high energy density batteries with longer life span   Roots Analysis has announced the addition of “Medical Device Batteries: Focus on Implants and Wearable Medical Devices - Market Distribution by Battery Chemistry (Lithium, Zinc Air, Nickel and Others), Rechargeability (Rechargeable and Non-Rechargeable), Applic

“Cancer Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing, 2019-2030” (Roots Analysis)

To order this detailed 370+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/cancer-biomarkers-market-focus-on-tmb-msi--mmr-and-tils-testing-2019--2030/253.html   Key Inclusions §  A detailed analysis of ongoing, biomarker-based clinical trials initiated by big pharmaceutical companies, featuring details on immuno-oncology biomarkers and disease indications being investigated, based on trial registration year, phase of development, recruitment s

Presently, close to 50 companies are offering a variety of analytical testing solutions for the assessment of novel cancer biomarkers (Roots Analysis)

Over time, pharmaceutical players have demonstrated significant interest in this domain and have launched clinical research initiatives to investigate the relevance and applications of these novel biomarkers. Several companies have already developed / are developing analytical tests for novel cancer biomarkers (TMB, MSI / MMR and TILs), intended to assist physicians in making personalized treatment decisions.   To order this 370+ page report, which features 190+ figures and 180+ tables

Cancer biomarkers market for TMB, MSI / MMR and TILs is projected to grow at an annualized rate of ~18% (till 2030)

Roots Analysis has done a detailed study on Cancer Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing, 2019–2030.” covering key aspects of the industry and identifying key future growth opportunities.   To order this 370+ page report, which features 190+ figures and 180+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/cancer-biomarkers-market-focus-on-tmb-msi--mmr-and-tils-testing-2019--2030/253.html   Key Market Insights §  Seve

Cancer biomarkers market for TMB, MSI / MMR and TILs is estimated to be worth USD 860 million in 2030 (Roots Analysis)

Advances in biotechnology have enabled the identification of several novel biomarkers, which are presently being used for a variety of purposes, including diagnosis, drug development, clinical research and to facilitate therapy-related decisions   Roots Analysis is pleased to announce the publication of its recent study, titled, “Cancer Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing, 2019–2030.”   The report features an extensive study of the current landscape an

“Targeted Protein Degradation Market, 2020-2030” < Roots Analysis>

To order this 330+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/protein-degradation-market/289.html   Key Inclusions §  A detailed assessment of the current market landscape of targeted protein degradation-based therapeutics, providing information on drug / therapy developer(s) (such as year of establishment, company size and location of headquarters), clinical study sponsor(s) and collaborator(s), type of protein degrader (degronimids, ENDT

More than 85 small molecule protein degraders are currently being evaluated <Roots Analysis>

The concept of targeted protein degradation presents revolutionary drug development opportunities and is anticipated to bring about a paradigm shift in modern healthcare. The first targeted protein degrader, called proteolysis targeting chimera (PROTAC), was developed about a decade ago. Presently, a variety of other such chemical entities and molecular glues are under investigation. In fact, certain pipeline candidates are already in the mid to late-phase trials and are anticipated to soon ente

Targeted protein degradation market is projected to grow at an annualized rate of more than 30% <till 2030>

Roots Analysis has done a detailed study on Targeted Protein Degradation Market: Focus on Therapeutics and Technology Platforms (based on Degronimids, ENDTACs, Epichaperome Inhibitors, Hydrophobic Tags, IMiDs, LYTACs, Molecular Glues, PHOTACs, PROTACs, Protein Homeostatic Modulators, SARDs, SERDs, SNIPERs, and Specific BET and DUB Inhibitors), 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 330+ page rep

“Next Generation Contact Lenses and Visual Prostheses Market, 2019-2030”

To order this detailed 230+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/next-generation-contact-lenses-and-visual-prostheses-market-2019-2030/244.html   Key Inclusions §  A detailed review of the landscape of novel ophthalmic products, highlighting the different categories of contact lenses and visual prostheses (bionic eye technologies) developed / being developed by various players across the world. It features information on the purpose

Over 55 novel ophthalmic products are currently available / being developed for various therapeutic

Advancements in the domain of ophthalmology continue to expand the range of potential application areas for contact lenses. Presently, over 55 novel ophthalmic products have been developed or are being developed for the treatment of various ophthalmological disorders, diagnosis / monitoring of diseases and for restoring vision in the blind. The ongoing efforts to innovate in this domain are evident from the fact that more than 7,500 patents have been granted / filed since 2013.   To or

The next generation contact lenses and visual prostheses market is projected to grow at an annualized rate of 52% <till 2030>

Roots Analysis has done a detailed study on “Next Generation Contact Lenses and Visual Prostheses Market, 2019-2030.”, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 230+ page report, which features 115+ figures and 110+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/next-generation-contact-lenses-and-visual-prostheses-market-2019-2030/244.html   Key Market Insights

The next generation contact lenses and visual prostheses market is estimated to be worth USD 3.7 billion in 2030 <Roots Analysis>

Recent technological advances in the field of ophthalmology and the availability of new biomaterials have substantially expanded the range of potential application areas of contact lenses and enabled the development of novel prosthetic products   Roots Analysis is pleased to announce the publication of its recent study, titled, “Next Generation Contact Lenses and Visual Prostheses Market, 2019-2030.”   The report features an extensive study of the current market landscape of

“Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030”

To order this detailed 350+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/immune-checkpoint-inhibitors/303.html   Key Inclusions §  A detailed assessment of the current market landscape, including information on drug developer(s), phase of development (marketed, clinical and preclinical / discovery stage) of lead candidates, target immune checkpoints, their respective mechanisms of action (inhibitory or stimulatory),  type of therapeutic moda

More than 150 industry players across the world are presently engaged in evaluating the potential of nearly 300 next generation immune

Over time, significant strides have been made in immune checkpoint research, resulting in the discovery of several inhibitory (LAG-3, TIM-3, TIGIT, VISTA and B7-H3) and stimulatory receptors (OX40, ICOS, GITR, 4-1BB and CD40), which are being investigated as potential targets for therapy development. Further, studies of combinatorial immune checkpoint blockade / co-stimulation, targeting newly identified checkpoints along with known checkpoint inhibitor therapies, have demonstrated promising cli

The next generation immune checkpoint inhibitors and stimulators market is projected to grow at an annualized rate of ~15%, till 2030

Roots Analysis has done a detailed study on Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 350+ page report, which features 140+ figures and 170+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/immune-checkpoint-inhibitors/303.html   Key Market Insights §  More than 150 industry players a

The next generation immune checkpoint inhibitors and stimulators market <Roots Analysis>

Therapies targeting novel inhibitory and stimulatory immune checkpoints have been shown to possess substantial therapeutic potential, both as monotherapies and in combination with other interventions, across multiple disease interventions   Roots Analysis is pleased to announce the publication of its recent study, titled, “Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030.”   The report features an extensive study of the current market landscape,

“Global Collaborative Robots (Cobots) Market, 2020-2030” <Roots Analysis>

To order this detailed 245+ page report, please visit this - https://www.rootsanalysis.com/reports/collaborative-robots-market.html   Key Inclusions §  An overview of the current market landscape of cobots, providing information on the market availability (available and under development), industrial task(s) performed (air blowing / spraying, CNC machine tending, gluing / dispensing / welding, loading / unloading, material handling, material removal / processing, packaging, pallet

Over 230 cobots, having variable payload capacities and degrees of freedom, have already been deployed

Collaborative robots or cobots allow companies to automate their processes, are easy to program and deploy, can increase productivity manifolds, and offer high returns on investment. It is worth noting that, according to the International Federation of Robotics (IFR), over time, the cost of cobots has decreased owing to growing demand for such machines across various industries, including automobiles, electronics / electrical goods, food and beverages, as well as life sciences / pharmaceuticals.

Global collaborative robots (cobots) market is projected to grow at an annualized rate of 34.4% <till 2030>

Roots Analysis has done a detailed study on Global Collaborative Robots (Cobots) Market, 2020-2030.” , covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 245+ page report, which features 80+ figures and 100+ tables, please visit this - https://www.rootsanalysis.com/reports/collaborative-robots-market.html   Key Market Insights §  Several players are currently engaged in the development and / or ma

Global collaborative robots (cobots) market is projected to be worth USD 18 billion by 2030 <Roots Analysis>

Given their flexibility and price to functionality ratio, cobots represent an ideal entry-level, automation model for both small and established companies, which do not intend to make very heavy large investments in automation   Roots Analysis is pleased to announce the publication of its recent study, titled, “Global Collaborative Robots (Cobots) Market, 2020-2030.”   The report features an extensive study of the potential applications, current landscape and the likely adopt

‘‘Drug Repurposing Service Providers Market, 2020-2030’’ <Roots Analysis>

To order this detailed 250+ page report, please visit this - https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html   Key Inclusions §  A detailed assessment of the current market landscape of companies offering drug repurposing services based on several relevant parameters, including year of establishment, company size, location of headquarters, type of company, type of service offered (drug discovery, consulting and others), purpose of repurposing, type of

Presently, over 65 companies claim to offer drug repurposing-related service <Roots Analysis>

Repurposing of marketed / shelved / pipeline candidates for the treatment of diseases (different from original target indications) has emerged as a viable business strategy. The rising popularity of this approach can further be attributed to various benefits, such as reduced development timelines, decreased investments and relatively higher success rates (considering that the safety profiles of such candidates have already been established).   To order this 250+ page report, which feat
×
  • Create New...